A chinese, multicenter, phase II trial of gefitinib (IRESSA) in patients with non-small cell lung cancer who had failed previous chemotherapy

被引：0
|
作者：
Guan, Z
Zhang, L
Li, L
Jiang, G
Liu, X
Chu, D
Li, W
机构：
[1] Sun Yat Sen Univ, Guangzhou, Guangdong, Peoples R China
[2] Peking Union Hosp, Beijing, Peoples R China
[3] Fudan Univ, Canc Hosp, Shanghai 200433, Peoples R China
[4] Peking Univ, Canc Hosp, Beijing 100871, Peoples R China
[5] Chinese Acad Med Sci, Canc Hosp, Beijing 100037, Peoples R China
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S246 / S246
页数：1
相关论文
共 50 条
  • [1] Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy
    Ahn, J.
    Kim, S.
    Ahn, M.
    Lee, J.
    Uhm, J.
    Sun, J.
    Park, K.
    Park, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy
    Kim, Seung Tae
    Uhm, Ji Eun
    Lee, Jeeyun
    Sun, Jong-mu
    Sohn, Insuk
    Kim, Seon Woo
    Jung, Sin-Ho
    Park, Yeon Hee
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    [J]. LUNG CANCER, 2012, 75 (01) : 82 - 88
  • [3] A PHASE II STUDY OF ERLOTINIB FOR PATIENTS WITH ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER WHO HAD FAILED GEFITINIB
    Lee, D. H.
    Kim, H. T.
    Kim, S.
    Suh, C.
    Lee, J.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 102 - 102
  • [4] Salvage therapy for Chinese non-small cell lung cancer patients who failed previous chemotherapy
    Chen, Yuh-Min
    Perng, Reury-Perng
    Shih, Jen-Fu
    Tsai, Chun-Ming
    Whang-Peng, Jacqueline
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (06) : 545 - 550
  • [5] Phase II trial of gefitinib in Chinese female patients with advanced non-small cell lung cancer
    Deng, J.
    Fang, W. J.
    Zhang, X. C.
    Chen, J.
    Qian, J.
    Mou, H. B.
    Xu, N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Gefitinib (Iressa) trials in non-small cell lung cancer
    Johnson, DH
    [J]. LUNG CANCER, 2003, 41 : S23 - S28
  • [7] Gefitinib (Iressa) for advanced non-small cell lung cancer
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2002, 44 (1138): : 77 - 78
  • [8] Phase II Study of Gefitinib Readministration in Patients with Advanced Non-Small Cell Lung Cancer and Previous Response to Gefitinib
    Asahina, Hajime
    Oizumi, Satoshi
    Inoue, Akira
    Kinoshita, Ichiro
    Ishida, Takashi
    Fujita, Yuka
    Sukoh, Noriaki
    Harada, Masao
    Maemondo, Makoto
    Saijo, Yasuo
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nukiwa, Toshihiro
    Nishimura, Masaharu
    [J]. ONCOLOGY, 2010, 79 (5-6) : 423 - 429
  • [9] Salvage therapy for elderly patients with advanced non-small cell lung cancer who failed previous chemotherapy
    Wu, Chieh-Hung
    Fan, Wen-Chien
    Chen, Yuh-Min
    Tsai, Chun-Ming
    Perng, Reury-Perng
    Lee, Yu-Chin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S546 - S547
  • [10] Phase II study of weekly paclitaxel in patients with non-small cell lung cancer who have failed previous treatments
    Yasuda, K
    Igishi, T
    Kawasaki, Y
    Kato, K
    Matsumoto, S
    Katayama, S
    Sako, T
    Shigeoka, Y
    Suyama, H
    Sugitani, A
    Yamamoto, M
    Hitsuda, Y
    Shimizu, E
    [J]. ONCOLOGY, 2004, 66 (05) : 347 - 352
12345